| BCBS New Mexico Medical Policies | Bioengineered Skin and Soft Tissue Substitutes | 2026-07-01 |
| BCBS New Mexico Medical Policies | Category III Current Procedural Terminology (CPT®) Codes | 2026-07-01 |
| BCBS New Mexico Medical Policies | Depemokimab-ulaa | 2026-07-01 |
| BCBS New Mexico Medical Policies | Efgartigimod alfa-fcab or Efgartigimod alfa and hyaluronidase- | 2026-07-01 |
| BCBS New Mexico Medical Policies | Etuvetidigene autotemcel | 2026-07-01 |
| BCBS New Mexico Medical Policies | Eyelid Thermal Pulsation for the Treatment of Dry Eye | 2026-07-01 |
| HealthPartners | Ocrelizumab (Ocrevus®) and ocrelizumab hya-ocsq | 2026-07-01 |
| HealthPartners | Oncology - obinutuzumab (Gazyva®) | 2026-07-01 |
| HealthPartners | Prostaglandin intracameral implant (iDose® TR, | 2026-07-01 |
| HealthPartners | Targeted therapies for Duchene muscular dystrophy | 2026-07-01 |